Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Hemispherx Biopharma's NDA for rintatolimod receives approval in Argentina

Aug. 24, 2016

Novel compound E-6887 shows promise for treating lupus

Aug. 24, 2016

Gilead begins phase III program for filgotinib in rheumatoid arthritis

Aug. 23, 2016

Medshine Discovery discloses JAK inhibitors

Aug. 12, 2016

MPC-300-IV shows dose-related improvements in phase II trial in biologic refractory RA

Aug. 11, 2016

Ablynx reports topline phase IIb results for vobarilizumab in patients with rheumatoid arthritis

Aug. 10, 2016

Autologous BMC is safe and effective in treating patients with atrophic non-unions

Aug. 8, 2016

Omeros' lead MASP-3 inhibitor shows efficacy in arthritis model

Aug. 5, 2016

Biogen initiates phase I trial of BIIB-068 in healthy subjects

Aug. 2, 2016

EMA accepts for review MAA for sarilumab

Aug. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...